Swarupa Chakole

Department of Community Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Science, Sawangi, India


  • Research   
    Comparison of Efficacy of Various Covid-19 Vaccines Available in India
    Author(s): Satvik* and Swarupa Chakole

    At the dawn of the year 2021 India began an extensive vaccination program aiming to vaccinate one hundred percent of its population. India's medication controller has endorsed utilization of Covishield and Covaxin. Several vaccines are yet to be approved but are in various phases of trial and may be available in the near future and are hence assessed in this article. The recent surge in number of COVID-19 cases across Europe even in nations having relatively high vaccination rates demanded a review of the efficacy of the available vaccines in our country. The risk of reinfection and need for booster doses needed to be assessed. In this review the articles on trials and efficacy of vaccines along with the protection provided against the delta variant of the virus have been assessed and the possible need of revaccinating the public in the event of another wave of infections sweeping.. Read More»

    Abstract HTML PDF